Pesquisa | BVS Violência e Saúde

1.

Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses.

Reed, Douglas S; Glass, Pamela J; Bakken, Russell R; Barth, James F; Lind, Cathleen M; da Silva, Luis; Hart, Mary Kate; Rayner, Jonathan; Alterson, Kim; Custer, Max; Dudek, Jeanne; Owens, Gary; Kamrud, Kurt I; Parker, Michael D; Smith, Jonathan.

J Virol ; 88(20): 12077-86, 2014 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-25122801

2.

Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus.

Herbert, Andrew S; Kuehne, Ana I; Barth, James F; Ortiz, Ramon A; Nichols, Donald K; Zak, Samantha E; Stonier, Spencer W; Muhammad, Majidat A; Bakken, Russell R; Prugar, Laura I; Olinger, Gene G; Groebner, Jennifer L; Lee, John S; Pratt, William D; Custer, Max; Kamrud, Kurt I; Smith, Jonathan F; Hart, Mary Kate; Dye, John M.

J Virol ; 87(9): 4952-64, 2013 May.

Artigo em Inglês | MEDLINE | ID: mdl-23408633

3.

A cell culture-derived influenza vaccine provides consistent protection against infection and reduces the duration and severity of disease in infected individuals.

Ehrlich, Hartmut J; Singer, Julia; Berezuk, Gregory; Fritsch, Sandor; Aichinger, Gerald; Hart, Mary Kate; El-Amin, Wael; Portsmouth, Daniel; Kistner, Otfried; Barrett, P Noel.

Clin Infect Dis ; 54(7): 946-54, 2012 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-22267715

4.

Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial.

Barrett, P Noel; Berezuk, Gregory; Fritsch, Sandor; Aichinger, Gerald; Hart, Mary Kate; El-Amin, Wael; Kistner, Otfried; Ehrlich, Hartmut J.

Lancet ; 377(9767): 751-9, 2011 Feb 26.

Artigo em Inglês | MEDLINE | ID: mdl-21329971

5.

Antibody to the E3 glycoprotein protects mice against lethal venezuelan equine encephalitis virus infection.

Parker, Michael D; Buckley, Marilyn J; Melanson, Vanessa R; Glass, Pamela J; Norwood, David; Hart, Mary Kate.

J Virol ; 84(24): 12683-90, 2010 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-20926570

6.

Recombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in mice.

Lehrer, Axel T; Wong, Teri-Ann S; Lieberman, Michael M; Humphreys, Tom; Clements, David E; Bakken, Russell R; Hart, Mary Kate; Pratt, William D; Dye, John M.

Vaccine ; 36(22): 3090-3100, 2018 05 24.

Artigo em Inglês | MEDLINE | ID: mdl-28216187

7.

Characterization of a Cynomolgus Macaque Model of Pneumonic Plague for Evaluation of Vaccine Efficacy.

Fellows, Patricia; Price, Jessica; Martin, Shannon; Metcalfe, Karen; Krile, Robert; Barnewall, Roy; Hart, Mary Kate; Lockman, Hank.

Clin Vaccine Immunol ; 22(9): 1070-8, 2015 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-26224691

8.

Phase I/II randomized double-blind study of the safety and immunogenicity of a nonadjuvanted vero cell culture-derived whole-virus H9N2 influenza vaccine in healthy adults.

Aichinger, Gerald; Grohmann-Izay, Barbara; van der Velden, Maikel V W; Fritsch, Sandor; Koska, Manuela; Portsmouth, Daniel; Hart, Mary Kate; El-Amin, Wael; Kistner, Otfried; Barrett, P Noel.

Clin Vaccine Immunol ; 22(1): 46-55, 2015 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-25355797

9.

Vaccine research efforts for filoviruses.

Hart, Mary Kate.

Int J Parasitol ; 33(5-6): 583-95, 2003 May.

Artigo em Inglês | MEDLINE | ID: mdl-12782057

10.

Advanced Development of the rF1V and rBV A/B Vaccines: Progress and Challenges.

Hart, Mary Kate; Saviolakis, George A; Welkos, Susan L; House, Robert V.

Adv Prev Med ; 2012: 731604, 2012.

Artigo em Inglês | MEDLINE | ID: mdl-22028978

11.

Clinical development of a Vero cell culture-derived seasonal influenza vaccine.

Ehrlich, Hartmut J; Berezuk, Gregory; Fritsch, Sandor; Aichinger, Gerald; Singer, Julia; Portsmouth, Daniel; Hart, Mary Kate; El-Amin, Wael; Kistner, Otfried; Barrett, P Noel.

Vaccine ; 30(29): 4377-86, 2012 Jun 19.

Artigo em Inglês | MEDLINE | ID: mdl-22172502

12.

Designing and testing broadly-protective filoviral vaccines optimized for cytotoxic T-lymphocyte epitope coverage.

Fenimore, Paul W; Muhammad, Majidat A; Fischer, William M; Foley, Brian T; Bakken, Russell R; Thurmond, James R; Yusim, Karina; Yoon, Hyejin; Parker, Michael; Hart, Mary Kate; Dye, John M; Korber, Bette; Kuiken, Carla.

PLoS One ; 7(10): e44769, 2012.

Artigo em Inglês | MEDLINE | ID: mdl-23056184

13.

Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB.

Martin, Shannon S; Bakken, Russell R; Lind, Cathleen M; Garcia, Patricia; Jenkins, Erin; Glass, Pamela J; Parker, Michael D; Hart, Mary Kate; Fine, Donald L.

Vaccine ; 28(4): 1031-40, 2010 Jan 22.

Artigo em Inglês | MEDLINE | ID: mdl-19914193

14.

Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus.

Martin, Shannon S; Bakken, Russell R; Lind, Cathleen M; Garcia, Patricia; Jenkins, Erin; Glass, Pamela J; Parker, Michael D; Hart, Mary Kate; Fine, Donald L.

Vaccine ; 28(18): 3143-51, 2010 Apr 19.

Artigo em Inglês | MEDLINE | ID: mdl-20193792

15.

Protection in mice passively immunized with serum from cynomolgus macaques and humans vaccinated with recombinant plague vaccine (rF1V).

Fellows, Patricia; Adamovicz, Jeffrey; Hartings, Justin; Sherwood, Robert; Mega, William; Brasel, Trevor; Barr, Ed; Holland, Lou; Lin, Winston; Rom, Amanda; Blackwelder, William; Price, Jessica; Morris, Stephen; Snow, Doris; Hart, Mary Kate.

Vaccine ; 28(49): 7748-56, 2010 Nov 16.

Artigo em Inglês | MEDLINE | ID: mdl-20920572

16.

Telemetric analysis to detect febrile responses in mice following vaccination with a live-attenuated virus vaccine.

Martin, Shannon S; Bakken, Russell R; Lind, Cathleen M; Reed, Douglas S; Price, Jessica L; Koeller, Craig A; Parker, Michael D; Hart, Mary Kate; Fine, Donald L.

Vaccine ; 27(49): 6814-23, 2009 Nov 16.

Artigo em Inglês | MEDLINE | ID: mdl-19761841

17.

Complex of a protective antibody with its Ebola virus GP peptide epitope: unusual features of a V lambda x light chain.

Lee, Jeffrey E; Kuehne, Ana; Abelson, Dafna M; Fusco, Marnie L; Hart, Mary Kate; Saphire, Erica Ollmann.

J Mol Biol ; 375(1): 202-16, 2008 Jan 04.

Artigo em Inglês | MEDLINE | ID: mdl-18005986

18.

Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.

Wang, Danher; Raja, Nicholas U; Trubey, Charles M; Juompan, Laure Y; Luo, Min; Woraratanadharm, Jan; Deitz, Stephen B; Yu, Hong; Swain, Benjamin M; Moore, Kevin M; Pratt, William D; Hart, Mary Kate; Dong, John Y.

J Virol ; 80(6): 2738-46, 2006 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-16501083

19.

Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins.

Olinger, Gene G; Bailey, Michael A; Dye, John M; Bakken, Russell; Kuehne, Ana; Kondig, John; Wilson, Julie; Hogan, Robert J; Hart, Mary Kate.

J Virol ; 79(22): 14189-96, 2005 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-16254354

20.

Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection.

Warfield, Kelly L; Olinger, Gene; Deal, Emily M; Swenson, Dana L; Bailey, Michael; Negley, Diane L; Hart, Mary Kate; Bavari, Sina.

J Immunol ; 175(2): 1184-91, 2005 Jul 15.

Artigo em Inglês | MEDLINE | ID: mdl-16002721

BVS Violência e Saúde

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar: